BioMADE has bought a Maple Grove site for $16.5M to build a $132M biomanufacturing facility backed by the DoD and Minnesota ...

Nonprofit manufacturer BioMADE says the plant will enable other businesses to test and develop novel technologies derived from living things.

A $132 million manufacturing campus — where companies will transform crops into industrial chemicals otherwise made with petroleum and often sourced from overseas — is coming to Maple Grove. The ...

BioMADE, a collaboration of public and private enterprise pursuing the manufacturing of "high-value" chemicals, materials, ...

Boston Bruins Prospect Will Zellers was named the USHL’s Player of the Year, shortly after winning Forward of the Year. Zellers had a brilliant season for the Green Bay Gamblers, where the 19-year-old ...

With that in mind, we've noticed some promising trends at Boston Scientific (NYSE:BSX) so let's look a bit deeper. AI is about to change healthcare. These 20 stocks are working on everything from ...

Boston Scientific BSX has been gaining from new product launches and accretive acquisitions. International expansion remains a key growth driver. The stock carries a Zacks Rank #2 (Buy).

BioMADE, a biomanufacturing nonprofit backed by the U.S. Department of Defense, will establish a $132 million flagship location at a site in Maple Grove.

Boston Scientific has a 12-month low of $70.97 and a 12-month high of $107.17. The business’s 50 day moving average is $98.68 and its 200-day moving average is $94.92.